Reimbursed with a limitationOriginator productATC B02BD10

Veyvondi

Veyvondi is an originator product from Takeda Pharma AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 509.60 to CHF 978.20 depending on the pack; the patient co-payment is 10 per cent plus the deductible.

Core data

Authorisation holder
Takeda Pharma AG
ATC code
B02BD10
IT group
06.01.10 Blutkonserven und Plasmafraktionen
Active substances
Vonicogum alfa
Preparation type
Originator product
On the SL since
01/12/2019
Last price change
01/05/2025
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Veyvondi Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Trockensub 650 IE c SolvSet 1 StkCHF 456.70CHF 509.6001/12/2019B7680666010013
Trockensub 1300 IE c SolvSet 1 StkCHF 913.40CHF 978.2001/12/2019B7680666010020

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/05/2025

Zur Prävention und Behandlung von Blutungen und operationsbedingten Blutungen bei der von-Willebrand-Krankheit für erwachsene Patienten, wenn eine alleinige Therapie mit Desmopressin (DDAVP) unwirksam oder kontraindiziert ist. VEYVONDI darf nicht zur Therapie von Hämophilie A eingesetzt werden.

FOPH wordingValid from 01/05/2014

Preisberechnung für Blutpräparate aufgrund des Fabrikabgabepreises zuzüglich einer Fixmarge wegen der speziellen Verteilersituation (praktisch kein Zwischenhandel) von Fr. 40.-- zuzüglich MWST. Diese Berechnung gilt nicht für die Humanalbumine.

FAQ

Is Veyvondi covered by Swiss health insurance?

Yes, but only under conditions. Veyvondi is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Veyvondi cost in Switzerland?

The public price is the maximum price set by the FOPH and for Veyvondi ranges from CHF 509.60 to CHF 978.20 per pack. The ex-factory price ranges from CHF 456.70 to CHF 913.40. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com